Clinical Trial Update: A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease [Phase 1]

View source ↗

Summary

A Phase 1, multi-center inhalation study of R7103 in patients with COPD was withdrawn from the trial program; the study examined safety, tolerability, pharmacod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• R7103

Snippet

Sponsor: Hoffmann-La Roche | Conditions: COPD | Phase 1 | Status: WITHDRAWN